Pharma and Biotech
Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -99.4% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 5.0 | n/a |
Pr/Book | 1.3 |
Latest | F'cast | |
---|---|---|
Revenue | -14.6% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-21 | 133.66 | (166.00) | 23.00p | 30.3 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 198.60 | (83.41) | (11.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 169.67 | (149.77) | (19.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
LTIP and DBP; Director/PDMR Notification | 12-Apr-2024 | 12:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 11-Apr-2024 | 16:00 | RNS |
Block Listing Interim Review | 08-Apr-2024 | 16:00 | RNS |
Oxford Nanopore tech used in 'groundbreaking' te... | 12-Apr-2024 | ShareCast |
Oxford Nanopore delays breakeven target as Covid... | 06-Mar-2024 | ShareCast |
Oxford Nanopore appoints new CFO | 22-Jan-2024 | ShareCast |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
11-Apr-24 | Transfer From | Nick Keher | 0.000p | 130 | £0.00 |
11-Apr-24 | Buy | Nick Keher | 115.00p | 130 | £149.50 |
06-Mar-24 | Buy | Duncan Tatton-Brown | 125.87p | 236,220 | £297,321.39 |
Currency | UK Pounds |
Share Price | 93.40p |
Change Today | -5.50p |
% Change | -5.56 % |
52 Week High | 275.00 |
52 Week Low | 92.95 |
Volume | 378,403 |
Shares Issued | 859.96m |
Market Cap | £803.20m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
12:12 | 711 @ 93.40p |
12:12 | 602 @ 93.40p |
12:12 | 846 @ 93.40p |
12:12 | 288 @ 93.40p |
12:12 | 1,000 @ 93.40p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research